BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W. 'Myocardial Ischemia-Reperfusion Injury and the Influence of Inflammation. Trends Cardiovasc Med 2022:S1050-1738(22)00029-9. [PMID: 35181472 DOI: 10.1016/j.tcm.2022.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang D, Wu H, Liu D, Li Y, Zhou G, Yang Q, Liu Y. Clinical efficacy of sacubitril-valsartan combined with acute ST-segment elevation myocardial infarction after reperfusion: A systematic review and meta-analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1036151] [Reference Citation Analysis]
2 Roefs MT, Heusermann W, Brans MAD, Snijders Blok C, Lei Z, Vader P, Sluijter JPG. Evaluation and manipulation of tissue and cellular distribution of cardiac progenitor cell-derived extracellular vesicles. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1052091] [Reference Citation Analysis]
3 Liu Y, Zhang J, Zhang D, Yu P, Zhang J, Yu S. Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury. Cells 2022;11:3271. [DOI: 10.3390/cells11203271] [Reference Citation Analysis]
4 He D, Hu J, Lu Y, Jia W, Wei M, Zeng X, Wang H, Liang S. The Effect of miR-505-5p on Inhibition of Serum Uromodulin Ameliorates Myocardial Inflammation and Apoptosis Induced by Ischemia-Reperfusion. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/3521971] [Reference Citation Analysis]
5 Rakhshan K, Sharifi M, Ramezani F, Azizi Y, Aboutaleb N. ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis. Mol Biol Rep 2022. [PMID: 36129600 DOI: 10.1007/s11033-022-07818-y] [Reference Citation Analysis]
6 Tan YQ, Lin F, Ding YK, Dai S, Liang YX, Zhang YS, Li J, Chen HW. Pharmacological properties of total flavonoids in Scutellaria baicalensis for the treatment of cardiovascular diseases. Phytomedicine 2022;107:154458. [PMID: 36152591 DOI: 10.1016/j.phymed.2022.154458] [Reference Citation Analysis]
7 Mokhtari B, Badalzadeh R. Protective and deleterious effects of autophagy in the setting of myocardial ischemia/reperfusion injury: an overview. Mol Biol Rep. [DOI: 10.1007/s11033-022-07837-9] [Reference Citation Analysis]
8 Lu Z, Deng M, Ma G, Chen L. TRIM38 protects H9c2 cells from hypoxia/reoxygenation injury via the TRAF6/TAK1/NF- κ B signalling pathway. PeerJ 2022;10:e13815. [DOI: 10.7717/peerj.13815] [Reference Citation Analysis]
9 Li Y, Gao Y, Li G. Preclinical multi-target strategies for myocardial ischemia-reperfusion injury. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.967115] [Reference Citation Analysis]
10 Zhou G, Peng Y, Guo M, Qu C, Luo S, Jiang Y, Chen D, Wang X, Guo Y. Esomeprazole inhibits endoplasmic reticulum stress and ameliorates myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 2022;627:84-90. [PMID: 36030656 DOI: 10.1016/j.bbrc.2022.08.013] [Reference Citation Analysis]
11 Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovasc Diabetol 2022;21:77. [PMID: 35570280 DOI: 10.1186/s12933-022-01506-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
12 Wang J, Li X, Peng G, Fan G, Zhang M, Chen J. Integrated Bioinformatics Analysis and Verification of Gene Targets for Myocardial Ischemia-Reperfusion Injury. Evid Based Complement Alternat Med 2022;2022:2056630. [PMID: 35463067 DOI: 10.1155/2022/2056630] [Reference Citation Analysis]
13 Zhai Y, Ao L, Yao Q, The E, Fullerton DA, Meng X. Elevated Expression of TLR2 in Aging Hearts Exacerbates Cardiac Inflammatory Response and Adverse Remodeling Following Ischemia and Reperfusion Injury. Front Immunol 2022;13:891570. [DOI: 10.3389/fimmu.2022.891570] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Penna C, Comità S, Tullio F, Alloatti G, Pagliaro P. Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.106995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Samaja M, Pagliaro P. Long and narrow road to win over myocardial ischemia-reperfusion injury. Trends in Cardiovascular Medicine 2022. [DOI: 10.1016/j.tcm.2022.02.013] [Reference Citation Analysis]